|
|
| Line 1: |
Line 1: |
| __NOTOC__ | | __NOTOC__ |
| {{Mixed connective tissue disease}} | | {{Microchapters}} |
| {{SI}}
| |
| {{CMG}}; {{AE}} {{CZ}}, {{JH}}, {{MIR}}
| |
|
| |
|
| {{SK}} MCTD; mixed connective tissue disorder; Sharp's syndrome | | {{CMG}}; {{AE}} Person 1, Person 2, Your Name |
|
| |
|
| ==Overview== | | ==[[Type page name here overview|Overview]]== |
| '''Mixed connective tissue disease''' ('''MCTD''') or ''Sharp's syndrome'' is a human [[autoimmune disease]] in which the [[immune system]] attacks the body. MCTD combines features of [[polymyositis]], [[systemic lupus erythematosus]], and [[systemic scleroderma]] and is thus considered an [[overlap syndrome]]. MCTD commonly causes [[arthritis|joint pain/swelling]], [[Raynaud phenomenon]], [[myositis|muscle inflammation]], and [[sclerodactyly|scarring of the skin of the hand]]. It does not typically cause [[kidney]] disease or [[seizure]]s. Distinguishing laboratory characteristics are a positive, speckled [[anti-nuclear antibody]] and an [[anti-U1-RNP antibody]].<ref>Venables PJ. ''Mixed connective tissue disease.'' Lupus. 2006;15(3):132-7. PMID 1663436</ref>
| |
| ==Pathophysiology== | |
| There are no specific histologic findings that aid in the diagnosis of [[Mixed Connective Tissue Disorder]] as a separate autoimmune disease. For example, [[nephritis]] in [[MCTD]] is usually indistinguishable from [[lupus]] nephritis.
| |
|
| |
|
| <div align="left">
| | ==[[Type page name here historical perspective|Historical Perspective]]== |
| <gallery heights="225" widths="225">
| |
| image:Fibrous Pericarditis in MCTD.jpg|Fibrous Pericarditis in MCTD
| |
| image:Cellular aggregates in perivascular space and adjacent myocardium.jpg|Cellular aggregates in perivascular space and adjacent myocardium
| |
| image:Cross Section of Intramural Coronary Artery.jpg|Cross Section of Intramural Coronary Artery
| |
| image:Small pulmonary artery in patient with MCTD and pulmonary hypertension.jpg|Small pulmonary artery in patient with MCTD and pulmnonary hypertension
| |
| </gallery>
| |
| </div>
| |
|
| |
|
| ==Historical Perspective== | | ==[[Type page name here classification|Classification]]== |
|
| |
|
|
| | ==[[Type page name here pathophysiology|Pathophysiology]]== |
| ==Classification== | |
|
| |
|
|
| | ==[[Type page name here causes|Causes]]== |
| ==Pathophysiology== | |
| *Associated Conditions:
| |
| **[[Systemic lupus erythematosus]]–like findings
| |
| ***[[Polyarthritis]]
| |
| ***[[Lymphadenopathy]]
| |
| ***Facial [[erythema]]
| |
| ***[[Pericarditis]] or [[pleuritis]]
| |
| ***[[Leukopenia]] (<4,000/mm3) or thrombocytopenia (<100,000/mm3)
| |
| **[[Scleroderma|Progressive Systemic Sclerosis]] –like findings
| |
| ***[[Sclerodactyly]]
| |
| ***[[Pulmonary fibrosis]], restrictive changes of the lung (forced vital capacity <80% of predicted), or reduced carbon monoxide diffusing capacity (<70% of predicted)
| |
| **[[Polymyositis]]-like findings
| |
|
| |
|
| ==Causes== | | ==[[Type page name here differential diagnosis|Differentiating Any Disease from other Diseases]]== |
|
| |
|
|
| | ==[[Type page name here epidemiology and demographics|Epidemiology and Demographics]]== |
| ==Differentiating Mixed Connective Tissue Disease from other Diseases== | |
|
| |
|
|
| | ==[[Type page name here risk factors|Risk Factors]]== |
| ==Epidemiology and Demographics== | |
|
| |
|
|
| | ==[[Type page name here screening|Screening]]== |
| ===Age=== | |
|
| |
|
|
| | ==[[Type page name here natural history, complications and prognosis|Natural History, Complications and Prognosis]]== |
| ===Gender===
| |
| | |
|
| |
| ===Race===
| |
| | |
| ==Risk Factors==
| |
| | |
|
| |
| ==Natural History, Complications and Prognosis== | |
| Cardiovascular abnormalities associated with mixed connective tissue disease are rare. Presence of any of the complications listed below indicates unfavorable prognosis;
| |
| *Acute [[pericarditis]] and/or [[pericardial effusion]],
| |
| *[[Mitral valve prolapse]],
| |
| *Intimal hyperplasia of coronary arteries,
| |
| *Perivascular and myocardial leukocytic infiltrates,
| |
| *[[Pulmonary hypertension]].
| |
| *Coronary Artery Disease (although it is rarer, ACS may occur secondary to vascular changes and underlying CAD. The youngest patient with MCTD and ACS in literature was 18 years old)<ref>Jang J J, Olin J W, Fuster V. A teenager with mixed connective tissue disease presenting with an acute coronary syndrome. Vascular Medicine; 2004, Vol. 9 Issue 1, 31-34</ref>
| |
| | |
| <div align="left">
| |
| <gallery heights="225" widths="225">
| |
| image:Teenager before PCI.jpg|A teenager with MCTD presented as ACS before PCI
| |
| image:Teenager post PCI.jpg|A teenager with MCTD presented as ACS post PCI
| |
| </gallery>
| |
| </div>
| |
|
| |
|
| ==Diagnosis== | | ==Diagnosis== |
| ===Diagnostic Criteria===
| | [[Type page name here history and symptoms|History and Symptoms]] | [[Type page name here physical examination|Physical Examination]] | [[Type page name here laboratory findings|Laboratory Findings]] | [[Type page name here electrocardiogram|Electrocardiogram]] | [[Type page name here chest x ray|Chest X Ray]] | [[Type page name here CT|CT]] | [[Type page name here MRI|MRI]] | [[Type page name here echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Type page name here other imaging findings|Other Imaging Findings]] | [[Type page name here other diagnostic studies|Other Diagnostic Studies]] |
| ===Symptoms===
| |
| *[[Raynaud’s phenomenon]]
| |
| *Swollen fingers or hands
| |
| *Muscle weakness
| |
| ===Physical examination===
| |
| | |
| ====Gallery====
| |
| | |
| =====Trunk=====
| |
| | |
| <gallery>
| |
| | |
| Image: Mixed_connective_tissue_disease_01.jpg|Mixed connective tissue disease. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/disease.jsf?diseaseId=12 With permission from Dermatology Atlas.]''<ref name="www.atlasdermatologico.com.br">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/disease.jsf?diseaseId=294>
| |
| | |
| </gallery>
| |
| | |
| =====Extremities=====
| |
|
| |
|
| <gallery>
| | ==Treatment== |
| | [[Type page name here medical therapy|Medical Therapy]] | [[Type page name here surgery|Surgery]] | [[Type page name here primary prevention|Primary Prevention]] | [[Type page name here secondary prevention|Secondary Prevention]] | [[Type page name here cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Type page name here future or investigational therapies|Future or Investigational Therapies]] |
|
| |
|
| Image: Mixed_connective_tissue_disease_02.jpg|Mixed connective tissue disease. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/disease.jsf?diseaseId=12 With permission from Dermatology Atlas.]''<ref name="www.atlasdermatologico.com.br">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/disease.jsf?diseaseId=294>
| | ==Case Studies== |
| | [[Type page name here case study one|Case #1]] |
|
| |
|
| Image: Mixed_connective_tissue_disease_03.jpg|Mixed connective tissue disease. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/disease.jsf?diseaseId=12 With permission from Dermatology Atlas.]''<ref name="www.atlasdermatologico.com.br">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/disease.jsf?diseaseId=294>
| |
|
| |
|
| </gallery>
| | [[Category:Projects]] |
| ===Laboratory Findings===
| | [[Category:Help]] |
| *Elevated serum level of muscle enzymes (creatine kinase)
| |
| *MCTD is characterized by anti–U1 small nuclear RNP positivity.
| |
| ===Imaging Findings===
| |
| **Myogenic pattern on electromyogram
| |
| ===Other Diagnostic Studies===
| |
| **Hypomotility or dilatation of esophagus
| |
|
| |
|
| == References ==
| | {{WH}} |
| {{reflist|2}} | | {{WS}} |